MedTrace Logo

S1204, Viral Screening in Newly Diagnosed Cancer Patients

NCT01946516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3051

Last updated 2023-07-03

Study results available
· View outcomes & findings →

Summary

The goal of this study is to estimate the prevalence of HIV, Hepatitis B and hepatitis C infection among newly diagnosed cancer patients presenting to community and academic oncology clinics.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Scott D. Ramsey, M.D. · Fred Hutchinson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-29
Primary Completion
2018-01-01
Completion
2022-10-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01946516 on ClinicalTrials.gov